These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16717350)

  • 1. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery.
    Morante L; Guasch EV; Palacio F; Gilsanz F
    Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm].
    Varela CA; Gómez JM; Reina MA; López A; Galindo S; Arruga AM
    Rev Esp Anestesiol Reanim; 2009 Apr; 56(4):245-8. PubMed ID: 19537265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
    Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
    J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
    Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of a potent investigational anticoagulant: idraparinux with recombinant factor VIIa.
    Dao A; Tuan B; Carlson N
    Am J Med; 2005 Oct; 118(10):1172-3. PubMed ID: 16194652
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after caesarean section--a case report.
    Sokolić V; Buković D; Fures R; Zadro M; Scurić I; Colak F; Celovec K; Boćan A
    Coll Antropol; 2002 Dec; 26 Suppl():155-7. PubMed ID: 12674848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII as a temporary reversal agent for warfarin anticoagulation: a cautionary report on an off-label application.
    Kalainov DM; Valentino LA
    Am J Orthop (Belle Mead NJ); 2008 Nov; 37(11):572-4. PubMed ID: 19104685
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
    Pepas LP; Arif-Adib M; Kadir RA
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
    Prosper SC; Goudge CS; Lupo VR
    Obstet Gynecol; 2007 Feb; 109(2 Pt2):524-5. PubMed ID: 17267882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sublingual haematoma: an unusual complication of oral anticoagulation therapy: about one case].
    Mouhaoui M; Khaleq K; Yaqini K; Louardi H
    Ann Fr Anesth Reanim; 2008 Jan; 27(1):94-6. PubMed ID: 18160249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy.
    Sanchis Cervera J; Andrés Blasco CJ; Mena-Duran AV
    Acta Haematol; 2003; 110(1):51-2. PubMed ID: 12975561
    [No Abstract]   [Full Text] [Related]  

  • 14. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
    Fernández MA; Andreu R; Fortea JM; Aznar J
    Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.
    McCarthy GC; Allen TK; Habib AS
    J Clin Anesth; 2012 Sep; 24(6):508-9. PubMed ID: 22986324
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy in 6 patients with Starr-Edwards heart valve prostheses.
    Ibarra-Pérez C; Del Bosque-Ruiz M
    Am J Cardiol; 1972 Oct; 30(5):565-8. PubMed ID: 5073671
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatment.
    Aiach M; Fiessinger JN; Capron L; Nussas C; Housset E; Leclerc M
    Thromb Haemost; 1982 Feb; 47(1):69-71. PubMed ID: 7071808
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
    Branch DW; Rodgers GM
    Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.